Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Duff Reaction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102002017B details a high-yield mixed acid method for producing febuxostat intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN119613239A details a high-yield Duff reaction route. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102002016A details a safer Febuxostat synthesis avoiding toxic cyanating agents. Discover cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN110878064A reveals a breakthrough synthesis route for febuxostat impurities, boosting total yield from 0.2% to 43% via strategic intermediate sequencing.
Patent CN117105817B details safe synthesis avoiding toxic cyanide. Reliable supplier for pharmaceutical intermediates ensuring cost reduction and supply continuity.
Patent CN113024399A details a novel Duff reaction route for high-purity Telmisartan intermediates, offering significant cost reduction and scalable production capabilities.